ORLANDO, Fla.--The combination of chemotherapies 5FU and oxaliplatin compared to 5FU alone after surgery for colon cancer decreases colon cancer recurrence and promotes longer survival for patients under 70 -- but not for those who are older, according to Mayo Clinic and Dana-Farber Cancer Institute scientists who will present their findings at the American Society of Clinical Oncology's (ASCO) annual meeting in Orlando, Fla.
Full article >>
Friday, May 29, 2009
Chemotherapy combination outcomes differ for aged, younger colon cancer patients
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment